This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Monosymptomatic Hypochondriacal Psychosis: Atypical Presentation and Response to Olanzapine

Prabhat K. Chand, MD, DNB; Sandip Anand, MBBS; and Pratima Murthy, DPM, MD

Published: June 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Monosymptomatic hypochondriacal psychosis (MHP)is an illness characterized by a single delusion of somatic typethat can present at any age from late adolescence onward,equally affecting both sexes and having a poor prognosis withouttreatment.1 Infestation with parasites, body dysmorphophobia,and halitosis are the most commonly reported somaticdelusions.1 Pimozide has been frequently used and reported tobe effective in the treatment of MHP, but has the potential for undesirable side effects including tardive dyskinesia and cardiacconduction defects.1‘ ‹’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Letter to the Editor

Stigma Kills Psychiatric Patients and Is Now Killing Clinical Research Too

Robert M. Post, MD, argues that NIMH should abandon the RDoC framework and restore funding for clinical...